Results

Total Results: 1,650 records

Showing results for "factor".

41. Disposition of Comments_Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-disposition-comments.pdf
    May 01, 2025 - dietary carbohydrate and digestible carbohydrate; clarified that gestational weight gain is a risk factor

42. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

43. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Oral DMARDs Anti-­‐tumor  necrosis  factor  drugs  vs.   … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Oral DMARDs Anti-tumor necrosis factor drugs vs.

44. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
    March 01, 2012 - Classes include oral antiplatelet agents, injectable LMWHs, injectable UFH, injectable or oral factor … factor Xa inhibitors vs. … LMWHs may be inferior to factor Xa inhibitors in terms of any, proximal, and distal DVTs but have a … As such, it is likely inferior to factor Xa inhibitors in the balance of benefits and harms as well … VKAs but higher bleeding; worse efficacy vs. factor Xa inhibitors but lower bleeding).

45. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - antibodies, monoclonal/adverse effects”[mh] OR “anti-inflammatory agents”[mh] OR ((“tumour necrosis factor … ”[tiab] OR “tumour necrosis factor-alpha”[tiab] OR “tumor necrosis factor”[tiab] OR “tumor necrosis … factor-alpha”[tiab] OR TNF[tiab] OR TNF- alpha[tiab]) AND (antibod*[tiab] OR antagonist[tiab] OR antagonists … Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy … KQ = Key question NMA = network meta-analysis RCT = randomized control trial TNF = tumor necrosis factor

46. Asthma-Immunotherapy-2011 Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
    January 01, 2011 - The checklist for risk factor studies had 26 subjects and nine response categories. … Factor _________ known gold standard _________ Loss of followup. … Define risk factor or list risk factors for which quality assessment would be the same. … measure exposure Hypothesis specific: complete for each risk factor. … Hypothesis specific: complete for each risk factor. Validation.

47. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - -32.mp. 7 bnp77-108.mp. 8 probnp.mp. 9 nt-probnp1-76.mp. 10 natriuretic factor … -32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … -32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … Prognostic Factor Measurement 3. … The prognostic factor of interest is adequately measured in study participants to sufficiently limit

48. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Current therapies, specifically human factor VIIa (NovoSeven ® ) and Feiba ™ , work by bypassing the … VIII product that serves as factor VIII replacement therapy by activating the natural coagulation … OBI-1 is an intravenous, recombinant, porcine factor VIII product that serves as factor VIII replacement … reducing immunogenicity of the antigen to recombinant porcine factor VIII. … Study of modified recombinant factor VIII (OBI-1) in subjects with congenital hemophilia A.

49. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
    January 01, 2011 - The most important risk factor for CIN, chronic kidney disease, is rising, driven in part by the increasing

50. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/musculoskeletal-complaints-tests-children/research-protocol

51. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
    January 01, 2007 - Three biologics (adalimumab, etanercept, and infliximab) are also classified as anti-tumor necrosis factor … elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor … Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor … Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients … Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor

52. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - has been identified by the Stroke Risk in Atrial Fibrillation Working Group as the strongest risk factor … IIa (thrombin) inhibitor dabigatran26 • ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa … • A factor IIa inhibitor (dabigatran) at a 110 mg dose is noninferior to warfarin for the composite … Factor IIa Inhibitor (Dabigatran 110 mg) vs. … For this evidence gap, we suggest focusing specifically on the comparative effectiveness of factor

53. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) • Direct thrombin Inh-DTI: Dabigatran • Factor … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … Xa inhibitor"[tiab] OR "factor Xa inhibitors"[tiab] OR "Blood clotting inhibitor"[tiab] OR "blood … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … Xa inhibitor"[tiab] OR "factor Xa inhibitors"[tiab] OR "Blood clotting inhibitor"[tiab] OR "blood

54. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
    January 01, 2009 - Aminosalicylates, corticosteroids, immune system suppressors, antibiotics, anti-diarrheals, anti-tumor necrosis factor

55. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

56. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

57. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … The etiology may involve more than one risk factor and interventions may have several components. … interventions for preventing dementia have looked at only the one-to-one relationship with a single risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor

58. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0405_01-16-2011.pdf
    January 01, 2011 - Cough is also an important factor in the spread of infectious disease.

59. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor

60. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor